LEADER 00000cam a2200709 i 4500 001 on1021286902 003 OCoLC 005 20190812134737.0 006 m o d f 007 cr bn||||a|||| 008 180202s2018 dcua ob f000 0 eng c 040 GPO|beng|erda|epn|cGPO|dOCLCO|dMERUC|dOCLCF|dUOK|dINT |dOCLCQ|dOCLCO|dGPO|dMvI 042 pcc 043 n-us--- 049 RIDW 050 4 KF26|b.L27 2016a 074 1043-C (online) 086 0 Y 4.L 11/4:S.HRG.114-730 090 KF26|b.L27 2016a 110 1 United States.|bCongress.|bSenate.|bCommittee on Health, Education, Labor, and Pensions,|0https://id.loc.gov/ authorities/names/no99015568|eauthor. 245 10 Generic drug user fee amendments :|baccelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016. 246 30 Accelerating patient access to generic drugs 264 1 Washington :|bU.S. Government Publishing Office,|c2018. 300 1 online resource (ii, 39 pages) :|billustrations. 336 text|btxt|2rdacontent 337 computer|bc|2rdamedia 338 online resource|bcr|2rdacarrier 340 |gmonochrome|2rdacc 347 text file|2rdaft 490 1 S. hrg. ;|v114-730 500 Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. 500 CRDP Program record. 504 Includes bibliographical references. 588 0 Online resource, PDF version; title from title page (Govinfo web site, viewed on Feb. 2, 2018). 650 0 Generic drugs|0https://id.loc.gov/authorities/subjects/ sh89000501|xPrices|0https://id.loc.gov/authorities/ subjects/sh2002006518|zUnited States.|0https://id.loc.gov/ authorities/names/n78095330-781 650 0 Drugs|xPrices|zUnited States.|0https://id.loc.gov/ authorities/subjects/sh2008102459 650 0 Prescription pricing|zUnited States.|0https://id.loc.gov/ authorities/subjects/sh2008109174 650 0 Drug accessibility|0https://id.loc.gov/authorities/ subjects/sh2009008270|xGovernment policy|0https:// id.loc.gov/authorities/subjects/sh99005269|zUnited States. |0https://id.loc.gov/authorities/names/n78095330-781 650 0 Drugs|xGeneric substitution.|0https://id.loc.gov/ authorities/subjects/sh85039731 650 0 Drug approval|zUnited States.|0https://id.loc.gov/ authorities/subjects/sh2009123884 650 7 Generic drugs|xPrices.|2fast|0https://id.worldcat.org/fast /939975 650 7 Generic drugs.|2fast|0https://id.worldcat.org/fast/939969 650 7 Drugs|xPrices.|2fast|0https://id.worldcat.org/fast/898879 650 7 Prescription pricing.|2fast|0https://id.worldcat.org/fast/ 1075656 650 7 Drug accessibility.|2fast|0https://id.worldcat.org/fast/ 1749120 650 7 Government policy.|2fast|0https://id.worldcat.org/fast/ 1353198 650 7 Drugs|xGeneric substitution.|2fast|0https:// id.worldcat.org/fast/898814 650 7 Drug approval.|2fast|0https://id.worldcat.org/fast/898661 650 7 Medication.|2homoit|0https://homosaurus.org/v3/ homoit0001007 651 7 United States.|2fast|0https://id.worldcat.org/fast/1204155 655 7 Legislative hearings.|2fast|0https://id.worldcat.org/fast/ 1910825 655 7 Legislative hearings.|2lcgft|0https://id.loc.gov/ authorities/genreForms/gf2013025047 776 08 |iPrint version:|aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. |tGeneric drug user fee amendments|w(OCoLC)1020497836 776 08 |iMicrofiche version:|aUnited States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. |tGeneric drug user fee amendments|w(OCoLC)1086348873 810 1 United States.|bCongress.|bSenate.|tS. hrg. ;|0https:// id.loc.gov/authorities/names/n83707917|v114-730. 856 40 |uhttps://purl.fdlp.gov/GPO/gpo88806 901 MARCIVE 20231220 948 |d20191118|cGPO|tfdlp changedonline aug-oct 158|lridw 948 |d20180926|clti|tlti-aex 948 |d20180309|cGPO|tfdlp newonline|lridw